Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

ClinicalTrials.gov ID: NCT00470470

Public ClinicalTrials.gov record NCT00470470. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 16, 2026, 2:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of Imatinib Mesylate (STI571;NSC#716051:IND 61135) in Patients With Inoperable AJCC Stage III or IV Melanoma Harboring Somatic Alterations of C-KIT

Study identification

NCT ID: NCT00470470
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: National Cancer Institute (NCI); NIH
Enrollment: 30 participants

Conditions and interventions

Conditions

Interventions

imatinib mesylate Drug
laboratory biomarker analysis Other

Drug · Other

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 31, 2007
Primary completion: Nov 30, 2013
Completion: Sep 30, 2014
Last update posted: Dec 22, 2014

2007 – 2014

United States locations

U.S. sites: 8
U.S. states: 3
U.S. cities: 4

Facility	City	State	ZIP	Site status
University of California at Los Angeles (UCLA )	Los Angeles	California	90095	—
Mount Sinai Medical Center CCOP	Miami Beach	Florida	33140	—
Good Samaritan Medical Center	West Palm Beach	Florida	33401	—
Palm Beach Cancer Institute-Main Office	West Palm Beach	Florida	33401	—
New York University Langone Medical Center	New York	New York	10016	—
Mount Sinai Medical Center	New York	New York	10029	—
Memorial Sloan Kettering Cancer Center	New York	New York	10065	—
Weill Medical College of Cornell University	New York	New York	10065	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00470470, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 22, 2014 · Synced May 16, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00470470 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →